Eric Kowarz
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
-
- CRISPR and Genetic Engineering
- RNA Research and Splicing
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Genomics and Chromatin Dynamics
- RNA Interference and Gene Delivery
Papers in
-
- Protein Degradation and Inhibitors 6
- RNA Interference and Gene Delivery 5
- Ubiquitin and proteasome pathways 4
- Advanced biosensing and bioanalysis techniques 4
- RNA Research and Splicing 3
- Genomics and Chromatin Dynamics 3
- Hematology 13
- Acute Myeloid Leukemia Research 11
- Co-authors
- Rolf Marschalek (23 shared papers)Claus Meyer (8 shared papers)Theo Dingermann (7 shared papers)Thomas Burmeister (3 shared papers)Kristin Wächter (1 shared paper)Björn Schneider (2 shared papers)Nicola Gökbuget (1 shared paper)Mara Molkentin (1 shared paper)
- Journals
- Blood (3 papers)Cancer Letters (2 papers)Biotechnology Journal (2 papers)Blood Advances (1 paper)iScience (1 paper)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Eric Kowarz
24 papers receiving 624 citations
Peers
Comparison fields: 5 of 77
- Hematology 119
- Molecular Biology 414
- Cancer Research 57
- Cell Biology 57
- Immunology 70
Countries citing papers authored by Eric Kowarz
This map shows the geographic impact of Eric Kowarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Kowarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Kowarz more than expected).
Fields of papers citing papers by Eric Kowarz
This network shows the impact of papers produced by Eric Kowarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Kowarz. The network helps show where Eric Kowarz may publish in the future.
Co-authors
The 25 scholars most cited alongside Eric Kowarz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 332 | |
| 2 | 2009 | 67 | |
| 3 | 2007 | 34 | |
| 4 | 2021 | 25 | |
| 5 | 2014 | 24 | |
| 6 | 2013 | 20 | |
| 7 | 2006 | 19 | |
| 8 | 2022 | 16 | |
| 9 | Premature transcript termination, trans-splicing and DNA repair: a vicious path to cancer. | 2011 | 16 |
| 10 | 2007 | 13 | |
| 11 | 2022 | 11 | |
| 12 | 2012 | 10 | |
| 13 | AF4 and AF4N protein complexes: recruitment of P-TEFb kinase, their interactome and potential functions. | 2015 | 10 |
| 14 | 2015 | 9 | |
| 15 | 2011 | 6 | |
| 16 | 2021 | 4 | |
| 17 | 2021 | 4 | |
| 18 | 2022 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2007 | 1 |
About Eric Kowarz
Eric Kowarz is a scholar working on Molecular Biology, Hematology, Genetics, Infectious Diseases and Pollution, having authored 24 papers that have together received 629 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (11 papers), Protein Degradation and Inhibitors (6 papers), Chronic Lymphocytic Leukemia Research (6 papers), RNA Interference and Gene Delivery (5 papers), Ubiquitin and proteasome pathways (4 papers), Advanced biosensing and bioanalysis techniques (4 papers), RNA Research and Splicing (3 papers) and Genomics and Chromatin Dynamics (3 papers). The work is most often cited by research in Hematology (119 citations), Molecular Biology (414 citations), Cancer Research (57 citations), Cell Biology (57 citations) and Immunology (70 citations). Eric Kowarz has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Rolf Marschalek, Claus Meyer, Theo Dingermann, Thomas Burmeister, Kristin Wächter, Björn Schneider, Nicola Gökbuget, Mara Molkentin, Stefan Schwartz and Dieter Hoelzer. Their work appears in journals such as Blood, Cancer Letters, Biotechnology Journal, Blood Advances and iScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.